WASHINGTON — The U.S. Food and Drug Administration has approved a reformulated version of ranitidine, which was sold widely under the brand name Zantac, allowing the acid-reducing drug to return to ...
Filing a Zantac claim is a crucial step toward securing justice and financial relief for those affected. By gathering essential documents, such as medical records, prescription proof, and evidence of ...